<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/229292-pharmaceutical-compositions-containing-fosfomycin-tromethamol by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 09:58:19 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 229292:PHARMACEUTICAL COMPOSITIONS CONTAINING FOSFOMYCIN TROMETHAMOL</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PHARMACEUTICAL COMPOSITIONS CONTAINING FOSFOMYCIN TROMETHAMOL</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>This invention relates to a pharmaceutical composition containing Fosfomycin Tromethamol, a stabilizer selected from the compounds as herein described, wherein the stabilizer is used in a molar ratio with respect to Fosfomycin Tromethamol comprised between 10% and 100%, and suitable excipients of pharmaceutical use.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>'Tharmaceutical compositions with antibiotic activity"<br>
The present invention concerns the use of certain salts and aminoacids as stabilizer of the<br>
antibiotic Fosfomycin Tromethamol and pharmaceutical compositions containing them.<br>
Fosfomycin Tromethamol (hereinafter FT) (The Merck Index XIII Ed., No. 4277, page 755),<br>
is a known antibiotic used for the treatment of urinary tract infections and it is the active<br>
ingredient, for example, of the drug named MONURIL®.<br>
FT is a compound relatively unstable because it presents reactive functional groups and can<br>
easily degrade due to the temperature and the humidity.<br>
This make difficult the storage of the raw material, the working and the preparation of<br>
pharmaceutical compositions (today exclusively in the form of hydrosolubie granulate) and<br>
the storage of the ready packages.<br>
For its use the granulate is dissolved in water and drunk. The acidity of the stomach too, may<br>
cause significant degradation phenomena which, in practice, reduce the amount of the active<br>
ingredient available to the absorption.<br>
We have now surprisingly found that some substances, when used in mixture with FT. are<br>
able to stabilize the antibiotic making it easier to handle for the operations of pharmaceutical<br>
technology and making stable the ready packages for a longer time.<br>
Furthermore, the degradation of FT at the pH of gastric juice results to be decreased when<br>
FT is in association with those substances.<br>
Therefore, the object of the present invention is the use of a substance selected from :<br>
tribasic sodium or potassium citrate<br>
monoacidic sodium or potassium citrate<br>
tribasic sodium or potassium phosphate<br>
monoacidic sodium or potassium phosphate<br>
sodium or potassium carbonate<br>
sodium or potassium bicarbonate<br>
sodium or potassium tartrate<br>
arginine<br>
lysine<br><br>
or mixtures thereof.<br>
to stabilize Fosfomycin Tromethamol.<br>
A second object of the present invention are the pharmaceutical compositions containing<br>
Fosfomycin Tromethamol, a compound selected from:<br>
tribasic sodium or potassium citrate<br>
monoacidic sodium or potassium citrate<br>
tribasic sodium or potassium phosphate<br>
monoacidic sodium or potassium phosphate<br>
sodium or potassium carbonate<br>
sodium or potassium bicarbonate<br>
sodium or potassium tartrate<br>
arginine<br>
lysine or mixtures thereof,<br>
and excipients suitable for the pharmaceutical use. Flereinalter, the substances the use of which is object of the invention will be jointly<br>
indicated as "stabilizer", meaning with that term also mixtures of two or more substances.<br>
I—<br>
The amount of stabilizer to be used is between 10% and l00% in moles with respect of FT.<br>
preferably between 30% and 70% and still more preferably about 50°'o.<br>
Among the above reported stabilizers, the presently preferred are tribasic sodium citrate.<br>
sodium or potassium carbonate or bicarbonate and arginine.<br>
The pharmaceutical compositions object of the invention are prepared from FT and the<br>
stabilizer by adding excipients for pharmaceutical use.<br>
The pharmaceutical form of FT presently preferred is that of hydrosoluble granules since,<br>
due to the relatively high amount of FT to be administered according to the instant posology<br>
(5.631 g), the solution obtained from the dissolution of granules in water is the most suitable<br>
and well accepted by the patients.<br>
With the new compositions of the invention it is possible to obtain formulations in granules<br>
but it is also possible to prepare hydrosoluble compositions obtainable by a simple admixture<br><br>
of FT, stabilizer and the other excipients, if any.<br>
Suitable excipients for the preparation of hydrosoluble compositions containing FT and a<br>
stabilizer are for example natural as well as artificial sweeteners or flavouring.<br>
Even if it is possible to add further excipients, useful for example for the granulation process,<br>
their use seems not to be necessary.<br>
The preparation of compositions of the invention can be conveniently carried out in different<br>
ways.<br>
It is possible,  for example, to prepare a semimanufactured granulate of FT to which<br>
successively the stabilizer, the flavouring and the sweetening are mixed and finally the<br>
whole is distributed in sachets.<br>
Alternatively, all the ingredients of the formulation can be mixed directly together.<br>
With the aim to better illustrate the present invention, the following examples are now given.<br>
Example 1 The stabilization of FT from the selected stabilizers was evaluated experimentally with the<br>
DSC technology;<br>
A mechanic mixture of FT (0,02 moles) with each of the stabilizers (0.01  moles) was<br>
admixed with 0.05% of water with respect to FT.<br>
The DCS technology used for each mixture (scanning  10°C/min.) allow to measure the<br>
reaction heat which develops after the melting peak of FT, due to the degradation reaction.<br>
A reduced heat development indicates a higher stabilization, the amount of FT being the<br>
same.<br>
The following values were obtained:<br>
FT (single substance)	=271.03±16.73 (J/g)<br>
FT+sodium citrate tribasic (dihydrate)	=119.19± 7.47 (J/g)<br>
FT+sodium bicarbonate	=143.32± 4.92 (J/g)<br>
FT+sodium carbonate	-115.84± 9.89 (J/g)<br>
FT+arginine	=175.25± 9.41 (J/g)<br>
The obtained data show as FT was effectively stabilized by adding the above mentioned<br>
substances. The heat of the degradation reaction, with the same amount of FT, was reduced<br><br>
in percentages between about 35 and 70%.<br>
Example 2 The stabilization of FT in simulated gastric juice was evaluated by reproducing the use<br>
conditions of the patient: 5.631 g of FT were additioned with 0.01 moles of the selected<br>
stabilizer and were dissolved in water (180 ml).<br>
The solution was poured in simulated gastric juice (100 ml, pH 1) and the degradation was<br>
measured as percentage recovery of the active ingredient in time.<br>
Already after 30 minutes the recovery of FT without stabilizer was 82% while with the<br>
stabilizer the recovery was 90%.<br>
Example 3 The following pharmaceutical compositions were prepared by simple admixture of the ingredients. Composition 1<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	1-125 g<br>
Aspartame	0.100 g<br>
Tangerine flavour	0.100 g<br>
Orange flavour	0.100 g<br>
Composition 2<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	0.500 g<br>
Sodium bicarbonate	0.840 g<br>
Aspartame	0.100 g<br>
Tangerine flavour	0.100 g<br>
Orange flavour	0.100 g<br>
Composition 3<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium bicarbonate	1 • 127 g<br>
Sodium carbonate	0.200 g<br><br>
Sucrose	2.000 g<br>
Tangerine flavour	0.100 g<br>
Lemon flavour	0.100 g<br>
Composition 4<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	0.734 g<br>
Sodium citrate monoacid	0.987 g<br>
Fructose	2.500 g<br>
Tangerine flavour	0.100 g<br>
Lemon flavour	0.100 g<br>
Composition 5<br>
Fosfomycin Tromethamol	5.631 g<br>
L-arginine	1.470 g<br>
Sodium Saccharin	0.010 g<br>
Sucrose	2.100 g<br>
Tanuerine flavour	0.100 a<br>
OrangS flavour	0.100 g<br>
Composition 6<br>
Fosfomycin Tromethamol	5.631 g<br>
L-arginine	0.500 g<br>
Lysine	O.lOOg<br>
Aspartame	0.100 g<br>
Tangerine flavour	0.100 g<br>
Orange flavour	0.070 g<br>
Composition 7<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	0.500 g<br>
Sodium carbonate	0.500 g<br>
Aspartame	O.lOOg<br><br>
Tangerine flavour	0.070 g<br>
Orange flavour	0.070 g<br>
Composition 8<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	1.000 g<br>
L-arginine	0.050 g<br>
Aspartame	0.070 g<br>
Orange flavour	0.150 g<br>
Lemon flavour	0.030 g<br>
Composition 9<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	1.800 g<br>
Sodium saccharin	0.040 g<br>
Sucrose	1.500 g<br>
Tangerin flavour	0.100 g<br>
Lemon flavour	0.100 g<br>
Composition 10<br>
Fosfomycin Tromethamol	5.631 g<br>
Sodium citrate dihydrate	L125 g<br>
Sorbitol	1.000 g<br>
Aspartame	0.070 g<br>
Tangerine flavour	0.100 g<br>
Orange flavour	0.100 g<br><br><br><br><br><br>
WE Claim<br>
1.	Use of a substance selected from:<br>
-	tribasic sodium or potassium citrate<br>
-	monoacidic sodium or potassium citrate<br>
-	tribasic sodium or potassium phosphate<br>
-	monoacidic sodium or potassium phosphate<br>
-	sodium or potassium carbonate<br>
-	sodium or potassium bicarbonate<br>
-	sodium or potassium tartrate<br>
-	arginine<br>
-	lysine<br>
or mixtures thereof,<br>
to stabilize Fosfomycin Tromethamol.<br>
2.	Use as stabilizer of a compound of claim 1, characterized in that the compound is selected among tribasic sodium citrate, sodium carbonate or arginine.<br>
3.	Use as stabilizer of a compound of claim 1, characterized in that the compound is used in a molar ratio with respect to FT comprised between 10% and 100%, preferably between 30% and 70% and still more preferably about 50%.<br>
4.	Pharmaceutical compositions containing Fosfomycin Tromethamol, a compound selected from:<br><br>
-	tribasic sodium or potassium citrate<br>
-	monoacidic sodium or potassium citrate<br>
-	tribasic sodium or potassium phosphate<br>
-	monoacidic sodium or potassium phosphate<br>
-	sodium or potassium carbonate<br>
-	sodium or potassium bicarbonate<br>
-	sodium or potassium tartrate<br>
-	arginine<br>
-	lysine<br><br>
or mixtures thereof,<br>
and suitable excipients of pharmaceutical use.<br>
5.	A composition according to claim 4, in the form of soluble granulate.<br>
6.	A composition according to claim 5 wherein the amount of FT contained for single dose is 5.631 g.<br>
7.	A composition according to claim 1 wherein the substance with stabilizing activity is selected among tribasic sodium citrate, sodium carbonate and arginine.<br>
8.	A composition according to claim 1 wherein the substance with stabilizing activity is used in a molar ratio with respect to FT comprised between 10% and 100%, preferably between 30% and 70% and still more preferably about 50%.<br><br>
9.     A composition, substantially as hereinabove described and exemplified.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzICBkZXNjcmlwdGlvbiAoY29tcGxldGUpIGdyYW50ZWQucGRm" target="_blank" style="word-wrap:break-word;">610-che-2003  description (complete) granted.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzIGZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">610-che-2003 form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzIGZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">610-che-2003 form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzIHBldGl0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">610-che-2003 petition.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzIHBvd2VyIG9mIGF0dG9ybmV5LnBkZg==" target="_blank" style="word-wrap:break-word;">610-che-2003 power of attorney.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">610-che-2003-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">610-che-2003-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWNvcnJlc3BvbmRlbmNlIG90aGVycyAucGRm" target="_blank" style="word-wrap:break-word;">610-che-2003-correspondence others .pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWRlc2NyaXB0aW9uIGNvbXBsZXRlLnBkZg==" target="_blank" style="word-wrap:break-word;">610-che-2003-description complete.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">610-che-2003-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjEwLWNoZS0yMDAzLWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">610-che-2003-form 18.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="229291-a-wheat-chocolate-bar-for-sustained-energy-release.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="229293-system-and-method-for-making-at-least-a-first-and-a-second-virtual-object-evolve-in-an-interactive-environment.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>229292</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>610/CHE/2003</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>12/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>20-Mar-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>16-Feb-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>29-Jul-2003</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ZAMBON GROUP S.p.A</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>VIA DELLA CHIMICA, 9, I-36100 VICENZA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>RAMPOLDI, LUCA</td>
											<td>VIA VERDI, 5, 20020 LAINATE</td>
										</tr>
										<tr>
											<td>2</td>
											<td>PIRRONE LUCA</td>
											<td>VIA M.L.KING 29, 35020 LEGNARO,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>FACCIN SARAH</td>
											<td>VIA TERRAGLIO 84, 30174 MESTRE,</td>
										</tr>
										<tr>
											<td>4</td>
											<td>GRASSANO ALESSANDRO</td>
											<td>VIA VOLTUTNO 21, 20052 MONZA,</td>
										</tr>
										<tr>
											<td>5</td>
											<td>GURRIERI GIOVANNI</td>
											<td>VIA MONTI LESSINI 7/E, 37023 GREZZANA,</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07G11/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>MI20020A001725</td>
									<td>2002-08-01</td>
								    <td>Italy</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/229292-pharmaceutical-compositions-containing-fosfomycin-tromethamol by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 09:58:20 GMT -->
</html>
